• Home
  • Canton Biologics
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 8A112
Book a meeting

Canton Biologics

About Canton Biologics

Canton Biologics is a globally integrated CDMO, operating four core sites across China and Germany and serving over 100 biopharma clients worldwide. Our capabilities span six advanced solution areas: Innovative Drug Solutions, Biosimilar Solutions, ATMP Solutions (including oncolytic viruses, CAR-T cell therapies, LBPs, and exosome-based therapies), Biologics Solutions for Companion Animals, Biologics Solutions for Livestock and Poultry, and Recombinant Products for Healthcare & Lifestyle. Supported by robust quality systems aligned with EMA, FDA, and NMPA standards, we enable the development of even the most challenging-to-express proteins. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 8A112
  • Country/Region:
    Hong Kong
  • Founded:
    2016
  • On CPHI since:
    2026
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contact info
  • +8615622163391
  • Website
  • UNIT 511 OF 5/F OF BUILDING 5W,, PHASE ONE, HONG KONG SCIENCE PARK, 000000, Hong Kong, Hong Kong
Show contact info Hide contact info

Products from Canton Biologics (6)

  • Biologics Development Solutions for Companion Animal Therapeutics

    Product Biologics Development Solutions for Companion Animal Therapeutics

    Leverages advanced expression technologies, optimised vectors, and flexible bioprocessing platforms to deliver scalable and cost‑efficient solutions tailored to companion animal biologics. Supports from early development to GMP manufacturing, with customisation for veterinary specific requirements.

  • Biomedical and Healthcare Recombinant Protein Solutions

    Product Biomedical and Healthcare Recombinant Protein Solutions

    Combines molecular engineering, host cell optimisation, expression system development, and process optimisation to address complex protein structures. The IgMax® platform enables production of pentameric IgM at high expression levels, with near‑complete pentamer assembly and excellent purity after downstre...
  • Innovative Drug Solutions for Difficult‑to‑Express and Complex Proteins

    Product Innovative Drug Solutions for Difficult‑to‑Express and Complex Proteins

    Integrated development and manufacturing solutions combining molecular engineering, vector optimization, host cell engineering, and customized process development. The platform delivers high titers for mAb production, and DTEasy™ strategies have demonstrated significant yield improvements across various di...
  • Integrated Biosimilar CMC Solutions – from Development to Commercial Manufacturing

    Product Integrated Biosimilar CMC Solutions – from Development to Commercial Manufacturing

    End‑to‑end biosimilar development from cell line construction to PPQ and commercial batches. The integrated platform enables a fast development timeline, supports global GMP requirements, and offers competitive cost of goods. Includes DS/DP manufacturing, analytical testing, quality support, and technology...
  • Integrated CMC Solutions for Advanced Therapies

    Product Integrated CMC Solutions for Advanced Therapies

    Customised CMC development and manufacturing for a broad range of advanced biologic modalities. Services include process development, analytical characterisation, scale‑up, and GMP manufacturing, tailored to the characteristics and development stage of each modality.

  • Recombinant Antigen and Vaccine Solutions for Livestock & Poultry

    Product Recombinant Antigen and Vaccine Solutions for Livestock & Poultry

    Combines advanced expression technologies with optimised vectors, cell culture processes, and downstream purification for high‑productivity and cost‑efficient manufacturing. Multimerisation and nanoparticle platforms enable the design of defined antigen structures in various multimeric forms, supporting ne...